🧬

Anti-Aging & Longevity

GHK-Cu, Epitalon, NAD+, and senolytic peptides for longevity, skin quality, and cellular rejuvenation research.

Compounds in This Category

Anti-Aging Peptides: Mechanism Overview

Longevity-focused peptide research targets four measurable biological hallmarks of aging: telomere attrition, epigenetic drift and gene expression dysregulation, NAD+ depletion, and accumulation of senescent cells. Compounds in this category address one or more of these pathways with evidence ranging from 50-year longitudinal human data (Epitalon) to recent preclinical senolytic work.

GHK-Cu — Gene Expression Modulation at Scale

GHK-Cu (Glycyl-L-histidyl-L-lysine copper(II) complex) is a naturally occurring tripeptide-copper chelate found in plasma, saliva, and urine. Plasma concentrations decline approximately 60% between ages 20 and 60, from ~200 ng/mL to ~80 ng/mL.

Genomic Effects

The 2012 Broad Institute analysis (Pickart et al.) using LINCS database gene expression profiling found GHK-Cu significantly modulates over 4,000 human genes. Key upregulated targets include:

  • Collagen I synthesis (+70% in fibroblast models)
  • Collagen III synthesis (+50%)
  • Elastin and glycosaminoglycan production
  • Antioxidant enzymes (superoxide dismutase, catalase)
  • VEGF and FGF: Angiogenic growth factors relevant to wound healing

Downregulated targets include genes associated with chronic inflammation (interleukins, TNF pathways) and cellular senescence markers.

Skin Research Context

In fibroblast culture studies, GHK-Cu reverses gene expression patterns that correlate with photoaging and chronological aging. It is among the most studied peptides for topical skin research, with both in vitro fibroblast data and randomized clinical trial data on wrinkle depth reduction.

Epitalon — Telomerase Activation

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation. It is the most studied synthetic telomerase activator outside of the TA-65/cycloastragenol class.

Mechanism

Epitalon activates telomerase reverse transcriptase (TERT) expression, promoting elongation of telomeric DNA sequences on chromosome ends. Shortened telomeres are a recognized biomarker of replicative senescence — the point at which cells cease division and enter a pro-inflammatory senescent state.

Evidence

Epitalon has over 50 years of research from the Khavinson group, including cell culture, rodent longevity, and human cohort data. A 2003 study in elderly volunteers showed measurable telomere length preservation in treated vs control groups at 3-year follow-up. It also stimulates pineal melatonin production, which has downstream effects on circadian regulation and oxidative stress.

NAD+ — Energy Metabolism and DNA Repair

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme central to cellular energy metabolism, sirtuin activation, and DNA repair via poly(ADP-ribose) polymerase (PARP) enzymes. NAD+ levels decline approximately 50% between ages 40 and 60 in humans, driven by increased PARP consumption during age-related DNA damage accumulation and CD38 upregulation in aging immune tissue.

NAD+ repletion is among the most extensively studied interventions in aging biology, with human clinical trials demonstrating safe elevation of NAD+ via precursor supplementation. Its role in SIRT1 and SIRT3 activation links it to mitochondrial biogenesis and metabolic regulation.

FOX04-DRI — Senolytic Peptide

Senescent cells — cells that have permanently exited the cell cycle — accumulate with age and secrete a pro-inflammatory cocktail termed the senescence-associated secretory phenotype (SASP). FOX04-DRI is a modified D-retro-inverso peptide that disrupts the FOXO4-p53 interaction in senescent cells, selectively triggering apoptosis in p21-positive senescent cells while leaving healthy cells unaffected.

Preclinical (mouse) data published in Cell (2017, Baar et al.) showed significant regeneration markers, fitness improvements, and hair regrowth following senescent cell clearance. No human trials exist as of the current evidence base.

Glutathione — Systemic Antioxidant Repletion

Glutathione is the primary intracellular antioxidant. Levels decline with age and are depleted under oxidative stress. Research contexts include its role in mitochondrial protection, metal detoxification, and immune cell function. Reduced (active) glutathione delivered IV is the standard research route, as oral bioavailability of intact glutathione is low.

Methylene Blue — Mitochondrial Electron Carrier

Methylene blue acts as an alternative electron carrier in the mitochondrial electron transport chain, bypassing Complex I/III dysfunction. At low doses (0.5–4 mg/kg), it improves mitochondrial efficiency and has demonstrated neuroprotective effects in multiple preclinical models. Human data is limited to case reports and small trials in Alzheimer's models.

Frequently Asked Questions

How does Epitalon affect telomere length and what is the quality of that evidence?

Epitalon upregulates TERT (telomerase reverse transcriptase) expression, the catalytic component of telomerase. Khavinson's 2003 human cohort study showed measurable telomere length preservation in elderly subjects at 3-year follow-up. The evidence base is extensive in volume but limited in independent replication — most data originates from the Khavinson group. Cell culture and rodent data are consistent. Human RCTs from independent groups remain lacking.

What does the GHK-Cu gene expression data actually show?

The 2012 Broad Institute analysis using the LINCS gene expression database found GHK-Cu modulates over 4,000 genes — a scale that exceeds most pharmaceutical compounds. Upregulated targets include collagen synthesis genes, antioxidant enzymes, and angiogenic factors. Downregulated targets include inflammation and senescence-associated genes. This is in vitro/database analysis, not a clinical trial outcome — the mechanistic basis is strong; clinical translation requires direct RCT validation.

What is FOX04-DRI and how selective is it for senescent cells?

FOX04-DRI is a D-retro-inverso peptide — a mirror-image, reversed-sequence peptide scaffold that resists proteolysis. It competes with endogenous FOXO4 for p53 binding, disrupting a survival signal that senescent cells depend on but healthy cells do not. The 2017 Cell paper demonstrated selective apoptosis in p21-positive senescent cells with minimal effect on non-senescent cell viability in culture. All data to date is preclinical (mouse).

Can GHK-Cu and Epitalon be used in the same protocol without conflict?

Yes — their mechanisms operate through entirely non-competing pathways. GHK-Cu acts at the gene expression level via chromatin remodelling and transcription factor modulation. Epitalon acts at the telomerase/pineal level affecting telomere maintenance and melatonin production. There is no known pharmacokinetic or pharmacodynamic interaction between the two. Combined use addresses distinct aging hallmarks: epigenetic drift (GHK-Cu) and telomere attrition (Epitalon).

Research Protocols

The Maxxing Stack →

Full protocol reference for building a comprehensive peptide stack.

Disclaimer

Research use only. Not for human consumption. All data referenced from preclinical or clinical research literature. Consult a qualified professional before any use.